Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of ENN0403 capsules to prevent cardiac surgery-associated acute kidney injury
CTR20243495Phase 2Active
- Sponsor
- Shanghai Yinuo Pharmaceutical
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ENN0403 in acute kidney failure (AKF), sponsored by Shanghai Yinuo Pharmaceutical. Started Sep 2024; status: active.
02
Drugs
ENN0403
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on CTR20243495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243495.